v3.26.1
Strategic Agreements - Additional Information (Details) - USD ($)
$ in Thousands
 1 Months Ended 12 Months Ended
Dec. 31, 2018
Dec. 31, 2025
Dec. 31, 2024
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]      
Derivative liabilities - royalty agreement   $ 2,041 $ 1,647
Ligand Development Funding Agreement [Member]      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]      
Payments totalling to fund development $ 15,000    
Maximum payments to receive upon achievement of milestones $ 8,000    
Agreement royalty term period from first sale 15 years    
Agreement termination notice period 90 days    
Aggregate potential future milestone payments remaining under arrangement   5,000 5,000
Derivative liabilities - royalty agreement   2,000 1,600
Long-term liability   $ 17,800 $ 11,900
Effective interest rate percentage of potential future royalty payments   44.90% 39.90%
Non-cash interest expense   $ 5,800 $ 3,900
Ligand Development Funding Agreement [Member] | Maximum      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]      
Royalty percentage 9.80%    
Ligand Development Funding Agreement [Member] | Minimum      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]      
Royalty percentage 8.00%